138 related articles for article (PubMed ID: 6968751)
41. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
Greer J
Enzyme; 1986; 36(1-2):150-63. PubMed ID: 3491754
[TBL] [Abstract][Full Text] [Related]
42. C3a-induced lysosomal enzyme secretion from human neutrophils: lack of inhibition by f met-leu-phe antagonists and inhibition by arachidonic acid antagonists.
Showell HJ; Glovsky MM; Ward PA
Int Arch Allergy Appl Immunol; 1982; 67(3):227-32. PubMed ID: 6800960
[TBL] [Abstract][Full Text] [Related]
43. Complete primary structure of human C4a anaphylatoxin.
Moon KE; Gorski JP; Hugli TE
J Biol Chem; 1981 Aug; 256(16):8685-92. PubMed ID: 6167582
[TBL] [Abstract][Full Text] [Related]
44. The role of serine-123 in the activity and specificity of ribonuclease. Reactivation of ribonuclease 1-118 by the synthetic COOH-terminal tetradecapeptide, ribonuclease 111-124, and its O-methylserine and alanine analogs.
Hodges RS; Merrifield RB
J Biol Chem; 1975 Feb; 250(4):1231-41. PubMed ID: 1112802
[TBL] [Abstract][Full Text] [Related]
45. Effects of human anaphylatoxins on guinea pig atria.
Huey R; Bloor CM; Hugli TE
Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
[TBL] [Abstract][Full Text] [Related]
46. Amino acid sequence of the active site of human serum cholinesterase from usual, atypical, and atypical-silent genotypes.
Lockridge O; La Du BN
Biochem Genet; 1986 Jun; 24(5-6):485-98. PubMed ID: 3741370
[TBL] [Abstract][Full Text] [Related]
47. Demonstration of a specific C3a receptor on guinea pig platelets.
Fukuoka Y; Hugli TE
J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
[TBL] [Abstract][Full Text] [Related]
48. Circular dichroism of C3a anaphylatoxin. Effects of pH, heat, guanidinium chloride, and mercaptoethanol on conformation and function.
Hugli TE; Morgan WT; Müller-Eberhard HJ
J Biol Chem; 1975 Feb; 250(4):1479-83. PubMed ID: 234458
[TBL] [Abstract][Full Text] [Related]
49. 'Tethered ligand' derived pentapeptide agonists of thrombin receptor: a study of side chain requirements for human platelet activation and GTPase stimulation.
Natarajan S; Riexinger D; Peluso M; Seiler SM
Int J Pept Protein Res; 1995 Feb; 45(2):145-51. PubMed ID: 7782162
[TBL] [Abstract][Full Text] [Related]
50. Scanning alanine mutagenesis and de-peptidization of a Candida albicans myristoyl-CoA:protein N-myristoyltransferase octapeptide substrate reveals three elements critical for molecular recognition.
McWherter CA; Rocque WJ; Zupec ME; Freeman SK; Brown DL; Devadas B; Getman DP; Sikorski JA; Gordon JI
J Biol Chem; 1997 May; 272(18):11874-80. PubMed ID: 9115247
[TBL] [Abstract][Full Text] [Related]
51. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets.
Becker S; Hadding U; Schorlemmer HU; Bitter-Suermann D
Scand J Immunol; 1978; 8(6):551-5. PubMed ID: 734357
[TBL] [Abstract][Full Text] [Related]
52. Characterization of human C4a anaphylatoxin.
Gorski JP; Hugli TE; Müller-Eberhard HJ
J Biol Chem; 1981 Mar; 256(6):2707-11. PubMed ID: 6970745
[TBL] [Abstract][Full Text] [Related]
53. Synthetic C3a analogs as specific inhibitors of C3a activity.
Meuer S; Hadding U; Andreatta R; Bitter-Suermann D
Immunopharmacology; 1981 Sep; 3(3):275-80. PubMed ID: 6975766
[TBL] [Abstract][Full Text] [Related]
54. Synthetic fragments of beta-casein as model substrates for liver and mammary gland casein kinases.
Meggio F; Perich JW; Meyer HE; Hoffmann-Posorske E; Lennon DP; Johns RB; Pinna LA
Eur J Biochem; 1989 Dec; 186(3):459-64. PubMed ID: 2606100
[TBL] [Abstract][Full Text] [Related]
55. Generation of anaphylatoxin activity related to C3a, by treatment of human serum with the nitrogen nucleophile N2H4 or the chaotrope KSCN.
von Zabern I; Damerau B; Nolte R; Grünefeld E; Vogt W
Scand J Immunol; 1985 Dec; 22(6):639-51. PubMed ID: 3937227
[TBL] [Abstract][Full Text] [Related]
56. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.
Morgan EL; Weigle WO; Hugli TE
J Exp Med; 1982 May; 155(5):1412-26. PubMed ID: 6978374
[TBL] [Abstract][Full Text] [Related]
57. Role of the complement anaphylatoxins in inflammation and hypersensitivity reactions in the lung.
Stimler-Gerard NP
Surv Synth Pathol Res; 1985; 4(5-6):423-42. PubMed ID: 3879815
[No Abstract] [Full Text] [Related]
58. Novel pentapeptide, PALAL, derived from a bony fish elicits contraction of the muscle in starfish Patiria pectinifera.
Go HJ; Kim CH; Oh HY; Park NG
J Pept Sci; 2016 Oct; 22(10):628-635. PubMed ID: 27506561
[TBL] [Abstract][Full Text] [Related]
59. Reevaluation of the C3a active site using short synthetic C3a analogues.
Köhl J; Casaretto M; Gier M; Karwath G; Gietz C; Bautsch W; Saunders D; Bitter-Suermann D
Eur J Immunol; 1990 Jul; 20(7):1463-8. PubMed ID: 2387312
[TBL] [Abstract][Full Text] [Related]
60. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
Stimler-Gerard NP
Complement; 1986; 3(3):137-51. PubMed ID: 3026723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
